Oct. 14 — Emerging technology is transforming the practice of medicine from an analog field of paper notebooks, textbooks and charts into a digital domain. This transition may emerge as one the most fundamental important tipping points since the discovery of penicillin, molecular biology, and the sequencing of the human genome.
The success of all of these research programs hinge on harnessing the power of HPC to analyze volumes of complex genomics and other biological datasets that simply can’t be processed by humans alone. The challenge for our community will be to develop the computing tools and services needed to transform how we think about disease and bring us closer to the next frontier in precision medicine.
This panel discussion will center on how this is only possible through the power of high performance computing and big data. Leading voices from the frontlines of clinical care, medical research, HPC system evolution, pharmaceutical R&D and public policy will share diverse perspectives on the future of precision medicine and how it will impact society.
HPC Impacts on Precision Medicine: Life’s Future–The Next Frontier in Healthcare
Panel Date/Location: 5:45-6:45 p.m. Monday, Nov. 14 in Ballroom-Full at the Salt Lake City Convention Center, Salt Lake City, Utah.
SC16 Panel Moderator:
- Mr. Steve Conway, Vice President of HPC Research, IDC
SC16 Invited Panelists:
- Dr. Mitchell Cohen, Director of Surgery, Denver Health Medical Center; Professor, University of Colorado School of Medicine.
- Dr. Martha Head, Senior Director, The Noldor; Acting Head, Insights from Data at GlaxoSmithKline Pharmaceuticals
- Dr. Dimitri Kusnezov, Chief Scientist & Senior Advisor to the Secretary, U.S. Department of Energy, National Nuclear Security Administration
- Dr. Steve Scott, Chief Technology Officer, Cray Inc.